Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam-ketamine delivery methods before pediatric eye surgery
IRCT20121205011676N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of midazolam and ketamine in preoperative anxiety (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Sedation level, Mask acceptance and 3 more. Started Aug 2024; status: completed.
02
Drugs
midazolamketamine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on IRCT20121205011676N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121205011676N6.